Liver-Directed Therapies for Hepatocellular Carcinoma

Authors: Cletus A. Arciero MD 1 and Elin R. Sigurdson MD, PhD 1
View More View Less
  • 1 From the Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Hepatocellular carcinoma (HCC) is a major cause of cancer-related death worldwide. This disease can be treated through several surgical and nonsurgical approaches. Although the only curative options for patients with HCC are surgical (resection or transplantation), most patients unfortunately present with advanced neoplastic disease or experience the effects of chronic liver disease, making surgical resection implausible. Several additional options are available for treating this population. Ablative therapies such as percutaneous ethanol injection, cryotherapy, radiofrequency ablation, laser ablation, and microwave hyperthermic ablation can be used with varying degrees of success. Transarterial chemoembolization can be used in patients with advanced disease or advanced chronic liver disease that cannot be treated with resection or ablation. This article explores the various liver-directed therapies, including surgical resection, and defines morbidity, mortality, and survival for each.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Correspondence: Elin R. Sigurdson, MD, PhD, Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111. E-mail: E_Sigurdson@fccc.edu
  • 1.

    Thomas MB, Zhu AX. Hepatocellular carcinoma: the need for progress. J Clin Oncol 2005;23:28922899.

  • 2.

    Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827841.

  • 3.

    A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998;28:751755.

    • Search Google Scholar
    • Export Citation
  • 4.

    Iwatsuki S, Starzl TE, Sheahan DG. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:2218; discussion 228–229.

    • Search Google Scholar
    • Export Citation
  • 5.

    Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790799; discussion 799–800.

    • Search Google Scholar
    • Export Citation
  • 6.

    Poon RT, Fan ST, Lo CM. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234:6370.

    • Search Google Scholar
    • Export Citation
  • 7.

    Vauthey JN, Klimstra D, Franceschi D. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995;169:2834; discussion 34–35.

    • Search Google Scholar
    • Export Citation
  • 8.

    Choi TK, Edward CS, Fan ST. Results of surgical resection for hepatocellular carcinoma. Hepatogastroenterology 1990;37:172175.

  • 9.

    Sugioka A, Tsuzuki T, Kanai T. Postresection prognosis of patients with hepatocellular carcinoma. Surgery 1993;113:612618.

  • 10.

    Nagorney DM, van Heerden JA, Ilstrup DM, Adson MA. Primary hepatic malignancy: surgical management and determinants of survival. Surgery 1989;106:740748; discussion 748–749.

    • Search Google Scholar
    • Export Citation
  • 11.

    Paquet KJ, Koussouris P, Mercado MA. Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study. Br J Surg 1991;78:459462.

    • Search Google Scholar
    • Export Citation
  • 12.

    Bruix J, Castells A, Bosch J. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:10181022.

    • Search Google Scholar
    • Export Citation
  • 13.

    Poon RT, Fan ST: Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg 2005;12:3137.

    • Search Google Scholar
    • Export Citation
  • 14.

    Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999;19:311322.

  • 15.

    Makuuchi M, Kosuge T, Takayama T. Surgery for small liver cancers. Semin Surg Oncol 1993;9:298304.

  • 16.

    Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001;88:165175.

  • 17.

    Farges O, Belghiti J, Kianmanesh R. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003;237:208217.

    • Search Google Scholar
    • Export Citation
  • 18.

    Makuuchi M, Sano K. The surgical approach to HCC: our progress and results in Japan. Liver Transpl 2004;10(suppl 1):S46S52.

  • 19.

    Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270285.

    • Search Google Scholar
    • Export Citation
  • 20.

    Tsuzuki T, Ogata Y, Iida S, Shimazu M. Hepatic resection in 125 patients. Arch Surg 1984;119:10251032.

  • 21.

    Chen MF, Jeng LB. Partial hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S329S334.

  • 22.

    Ozawa K, Takayasu T, Kumada K. Experience with 225 hepatic resections for hepatocellular carcinoma over a 4-year period. Am J Surg 1991;161:677682.

    • Search Google Scholar
    • Export Citation
  • 23.

    Yamanaka N, Okamoto E, Toyosaka A. Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 1990;65:11041110.

    • Search Google Scholar
    • Export Citation
  • 24.

    Parker GA, Lawrence W Jr, Horsley JS 3rd. Intraoperative ultrasound of the liver affects operative decision making. Ann Surg 1989;209:569576; discussion 576–577.

    • Search Google Scholar
    • Export Citation
  • 25.

    Zhou XD, Tang ZY, Yang BH. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001;91:14791486.

    • Search Google Scholar
    • Export Citation
  • 26.

    Liu CL, Fan ST, Lo CM. Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol 2001;19:37253732.

    • Search Google Scholar
    • Export Citation
  • 27.

    Ng KK, Vauthey JN, Pawlik TM. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005;12:364373.

    • Search Google Scholar
    • Export Citation
  • 28.

    Lee KW, Park JW, Joh JW. Can we expand the Milan criteria for hepatocellular carcinoma in living donor liver transplantation? Transplant Proc 2004;36:22892290.

    • Search Google Scholar
    • Export Citation
  • 29.

    Arii S, Yamaoka Y, Futagawa S. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000;32:12241229.

    • Search Google Scholar
    • Export Citation
  • 30.

    Nonami T, Harada A, Kurokawa T. Hepatic resection for hepatocellular carcinoma. Am J Surg 1997;173:288291.

  • 31.

    Takayama T, Makuuchi M, Hirohashi S. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998;28:12411246.

    • Search Google Scholar
    • Export Citation
  • 32.

    Livraghi T, Giorgio A, Marin G. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101108.

    • Search Google Scholar
    • Export Citation
  • 33.

    Livraghi T, Benedini V, Lazzaroni S. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998;83:4857.

    • Search Google Scholar
    • Export Citation
  • 34.

    Giorgio A, Tarantino L, de Stefano G. Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients. Eur J Ultrasound 2000;12:145154.

    • Search Google Scholar
    • Export Citation
  • 35.

    Lencioni RA, Allgaier HP, Cioni D. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235240.

    • Search Google Scholar
    • Export Citation
  • 36.

    Livraghi T, Bolondi L, Lazzaroni S. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992;69:925929.

    • Search Google Scholar
    • Export Citation
  • 37.

    Okuda K. Intratumor ethanol injection. J Surg Oncol 1993;3(suppl):9799.

  • 38.

    Castells A, Bruix J, Bru C. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993;18:11211126.

    • Search Google Scholar
    • Export Citation
  • 39.

    Huang GT, Lee PH, Tsang YM. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 2005;242:3642.

    • Search Google Scholar
    • Export Citation
  • 40.

    Chen MS, Li JQ, Zheng Y. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321328.

    • Search Google Scholar
    • Export Citation
  • 41.

    Jansen MC, van Hillegersberg R, Chamuleau RA. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol 2005;31:331347.

    • Search Google Scholar
    • Export Citation
  • 42.

    Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb 1998;43:141154.

  • 43.

    Pearson AS, Izzo F, Fleming RY. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999;178:592599.

  • 44.

    Zhou XD, Tang ZY. Cryotherapy for primary liver cancer. Semin Surg Oncol 1998;14:171174.

  • 45.

    Curley SA, Izzo F, Ellis LM. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381391.

  • 46.

    Livraghi T, Solbiati L, Meloni MF. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441451.

    • Search Google Scholar
    • Export Citation
  • 47.

    de Baere T, Risse O, Kuoch V. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003;181:695700.

  • 48.

    Livraghi T, Goldberg SN, Lazzaroni S. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655661.

    • Search Google Scholar
    • Export Citation
  • 49.

    Livraghi T, Goldberg SN, Lazzaroni S. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000;214:761768.

    • Search Google Scholar
    • Export Citation
  • 50.

    Tateishi R, Shiina S, Teratani T. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005;103:12011209.

    • Search Google Scholar
    • Export Citation
  • 51.

    Barnett CC Jr, Curley SA. Ablative techniques for hepatocellular carcinoma. Semin Oncol 2001;28:487496.

  • 52.

    Shiina S, Teratani T, Obi S. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122130.

    • Search Google Scholar
    • Export Citation
  • 53.

    Lin SM, Lin CJ, Lin CC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004;127:17141723.

    • Search Google Scholar
    • Export Citation
  • 54.

    Lin SM, Lin CJ, Lin CC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:11511156.

    • Search Google Scholar
    • Export Citation
  • 55.

    Sakr AA, Saleh AA, Moeaty AA. The combined effect of radiofrequency and ethanol ablation in the management of large hepatocellular carcinoma. Eur J Radiol 2005;54:418425.

    • Search Google Scholar
    • Export Citation
  • 56.

    Giorgio A, Tarantino L, de Stefano G. Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients. Eur J Ultrasound 2000;11:181188.

    • Search Google Scholar
    • Export Citation
  • 57.

    Verhoef C, Kuiper JW, Heisterkamp J. Interstitial laser coagulation with temporary hepatic artery occlusion for patients with cirrhosis and irresectable hepatoma. Br J Surg 2003;90:950955.

    • Search Google Scholar
    • Export Citation
  • 58.

    Pacella CM, Bizzarri G, Magnolfi F. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology 2001;221:712720.

    • Search Google Scholar
    • Export Citation
  • 59.

    Dong B, Liang P, Yu X. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol 2003;180:15471555.

    • Search Google Scholar
    • Export Citation
  • 60.

    Liang P, Dong B, Yu X. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005;235:299307.

    • Search Google Scholar
    • Export Citation
  • 61.

    Lu MD, Xu HX, Xie XY. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol 2005;40:10541060.

    • Search Google Scholar
    • Export Citation
  • 62.

    Colleoni M, Audisio RA, De Braud F. Practical considerations in the treatment of hepatocellular carcinoma. Drugs 1998;55:367382.

  • 63.

    A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. N Engl J Med 1995;332:12561261.

    • Search Google Scholar
    • Export Citation
  • 64.

    Pelletier G, Ducreux M, Gay F. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol 1998;29:129134.

    • Search Google Scholar
    • Export Citation
  • 65.

    Lo CM, Ngan H, Tso WK. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:11641171.

    • Search Google Scholar
    • Export Citation
  • 66.

    Llovet JM, Real MI, Montana X. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:17341739.

    • Search Google Scholar
    • Export Citation
  • 67.

    Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003;37:429442.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 92 67 45
PDF Downloads 69 60 44
EPUB Downloads 0 0 0